Lung Cancer Journal @LungCaJournal
Journal on clinical, translational & basic science of lung & chest malignancies #LCSM. Affiliated with @myESMO, @BTOGORG, @ETOP_eu and ILCCO lungcancerjournal.info Amsterdam, the Netherlands Joined February 2021-
Tweets153
-
Followers2K
-
Following143
-
Likes221
🚨📝 A pragmatic guide for management of adverse events associated with lorlatinib Link here 👉lungcancerjournal.info/article/S0169-… #LCSM @ALKPositiveinc
Outcomes with chemo-immunotherapy by #KRAS, STK11, and KEAP1 across PDL1 strata @LungCaJournal. KRAS mt enriched in PDL1 high but KRAS with co-mutations in STK11 and KEAP1 enriched in PDL1 negative. Poor OS in KRAS mt with PDL1 0% driven by STK11/KEAP1. lungcancerjournal.info/article/S0169-…
Current Trial Report on the TARGET trial TARGET is a phase II, open-label, single-arm study of 5-year adjuvant #osimertinib in completely resected EGFR-mutated stage II to IIIB NSCLC Primary endpoint: investigator-assessed DFS at 5 years More: bit.ly/46P0VcO
See this month’s highlights from the @myESMO portfolio. Featured content from @Annals_Oncology, @ESMO_Open, @esmo_iotech, @TheBreastOnline, @LungCaJournal, Cancer Treatment Reviews and Clinical Lymphoma Myeloma and Leukemia spkl.io/60134dyVR
Happy to see our work on KL-6/MUC1 in pleural meso now out in @LungCaJournal: ➤ KL-6 lvls in pleural eff were diagnostic in 2 indep cohorts of pts with pleural meso. ➤⬆️KL-6 lvls and ⬆️MUC1 mRNA expression were associated with⬆️patient outcome. 👉lungcancerjournal.info/article/S0169-…
💡#LCSM a new review by @FordePatrick and colleagues, not to be missed!! Neoadjuvant immunotherapy in NSCLC!!! 🚨 lungcancerjournal.info/action/consume…
💡#LCSM a new review by @FordePatrick and colleagues, not to be missed!! Neoadjuvant immunotherapy in NSCLC!!! 🚨 lungcancerjournal.info/action/consume…
🆕Just out in @LungCaJournal this interesting editorial by @DrJNaidoo & . @FCortiula discussing the role of neoadjuvant Osimertinib in resectable NSCLC, harbouring EGFR mutations #LCSM Here the link: lungcancerjournal.info/article/S0169-…
See this month’s highlights from the @myESMO portfolio. Featured content from @Annals_Oncology, @ESMO_Open, @esmo_iotech, @TheBreastOnline, @LungCaJournal, Cancer Treatment Reviews and Clinical Lymphoma Myeloma and Leukemia spkl.io/60114dyyV
🚨🆕 Just out in @LungCaJournal this review by @MarianaBrandao0 et al, discussing “Systemic treatment & radiotherapy for pts with NSCLC & #HIV infection” #LCSM Find it here 🔗lungcancerjournal.info/article/S0169-…
The European Lung Cancer Congress is ready to start in a few of days *Official hashtag: #ELCC23 👈🏻
🚨just out in @LungCaJournal this important review lead by @MartinReck2 discussing the role of anti-angiogenic agents for the treatment of resistant NSCLC: rationale, recent updated and perspectives #LCSM 🔗 sciencedirect.com/science/articl…
TROP2 expression and SN38 antitumor activity in malignant pleural #mesothelioma cells provide a rationale for antibody-drug conjugate therapy #LCMS #meso lungcancerjournal.info/article/S0169-…
Age-period-cohort effect on lung cancer mortality in Spain, 1982-2021 #LCSM 🇪🇸 lungcancerjournal.info/article/S0169-…
🚨just out in @LungCaJournal MET Alterations in Advanced NSCLC @metcrusaders #LCSM lungcancerjournal.info/article/S0169-…
Have you registered for #BTOG23 yet? Our fantastic programme of expert speakers is available on our website. Join us in Belfast for this event that's not to be missed by anyone working in the field of #LungCancer ow.ly/uY9S50MVp0k
🆕🗞️Out in the @LungCaJournal an excellent review investigating *Primary endpoints to assess the efficacy of novel therapeutic approaches in EGFR-mutated, surgically resectable NSCLC #LCSM lungcancerjournal.info/article/S0169-…
New ESMO Guideline: Oncogene-Addicted #mNSCLC. Developed due to rapid advances in biomarker identification & targeted therapies; updated recommendations & tx algorithms on new & clinically relevant biomarker identification, targeting & adv disease managemt ow.ly/uV7X50MyPeA
💡🔥Out today, the Oncogene-addicted metastatic NSCLC ESMO Guideline. A significant effort to improve the management of patients w/ #lungcancer harbouring 🔟 different gene alterations! This is an amazing manuscript & I am glad to be a part of it #LCSM sciencedirect.com/science/articl…
💥🔥just out in @Annals_Oncology, the NEW @myESMO guideline for non-oncogene addicted metastatic NSCLC #LCSM ‼️ Honoured to be part of this important document (waiting for oncogene addicted one), lead by @HendriksLizza & @MartinReck2 annalsofoncology.org/article/S0923-…
Stephen V Liu, MD @StephenVLiu
24K Followers 3K Following Director of Thoracic Oncology & Developmental Therapeutics @Georgetown @LombardiCancer; Host @IASLC Podcast; Chair #DCLung24 #TexasLung24 #HereWeGo
Vivek Subbiah, MD @VivekSubbiah
34K Followers 2K Following Chief, Early-Phase Drug Development|@SarahCannonDocs #Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.
Jarushka Naidoo @DrJNaidoo
9K Followers 936 Following Professor of Medical Oncology @CancerCentreIre | Thoracic Oncologist | Immunotherapy & Immune toxicity | Adjunct faculty Johns Hopkins University
ESMO - Eur. Oncology @myESMO
75K Followers 874 Following The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology community’s work.
IASLC @IASLC
19K Followers 2K Following The International Association for the Study of Lung Cancer is the only global organization dedicated solely to the study of lung cancer. #LCSM
Balazs Halmos @DrSteveMartin
8K Followers 3K Following Thoracic/precision oncology 🇭🇺🇺🇸 Country music singer- The White Lungs
Sanjay Popat @DrSanjayPopat
7K Followers 591 Following Thoracic Oncologist @royalmarsdenNHS, Professor @ICR_London; Chair @BTOGorg; views are my own.
Aakash Desai, MD, MPH @ADesaiMD
5K Followers 1K Following Thoracic/Phase 1 Oncologist @ONealCancerUAB, Asst Prof @UABMedicine | Alum @MayoHemeOnc @UConnIM @MDAndersonNews| Co-Host @HemOncFellows @LungCancerRX
Andres F. Cardona @AndresFCardonaZ
8K Followers 4K Following Pursue knowledge, mentor students, collaborate globally, and push boundaries. Everything else is just noise in the academic concert.
Ivy Elkins @ivybelkins
6K Followers 4K Following Co-Founder, @EGFRResisters LC Patient Group; writer for https://t.co/W6HLnN0ibZ; lc advocate/survivor; dx stage IV 2013, @Princeton & @Wharton alum.
Dr. Estela Rodriguez @Latinamd
6K Followers 3K Following Associate Director Community Outreach- DEI- 🫁Thoracic Oncology, University of Miami @SylvesterCancer , 🇵🇷Boricua, Co-founder @KidsHelpingKidsSucceed
H. Jack West, MD @JackWestMD
22K Followers 3K Following VP of Clin Development, @summitplc; Founder,@CancerGRACE; fmr author/ed @UptoDate, fmr Web Ed @JAMAOnc & @MedscapeOnc columnist; Likes/RTs ≠ endorsement
International Lung Ca.. @LungSummit
2K Followers 2K Following An interactive conference for thoracic experts to discuss recent advances in the treatment of #LungCancer. Bridging the gap in thoracic oncology together.
Jill Feldman @jillfeldman4
8K Followers 4K Following Lung Cancer Patient and Advocate, Co-Founder @EGFRResisters, wife, mom of 4, #LCSM #lungcancer #HealthEquity #EndStigma #RockChalk
BTOG @BTOGORG
4K Followers 428 Following British Thoracic Oncology Group (BTOG) - multi-disciplinary group for professionals involved with thoracic malignancies.
Umberto Malapelle @UmbertoMalapel1
3K Followers 594 Following Predictive Molecular Pathology and Next Generation Technologies on Tissue and Liquid Biopsy. Tweet reflect my personal opinions!
Rami Manochakian MD, .. @RManochakian
3K Followers 667 Following Associate Professor/Thoracic Oncologist/Vice Chair-Education/#HemOnc Fellowship Director @MayoClinic FL/Assoc Editor @ASCO #Education #LungCancer #أورام #طبيب
Nathan A. Pennell MD,.. @n8pennell
13K Followers 1K Following Professor and thoracic oncologist, Vice Chair Clin Res @ClevelandClinic Cancer Inst, @ASCO #EdBook Editor in Chief, Dad, Steelers fan. All opinions mine. #LCSM
Brendon Stiles @BrendonStilesMD
10K Followers 2K Following Thoracic surgeon expecting excellence. Cancer researcher. Patient advocate. #LungCancer #lcsm @lung_fund
Ben Solomon @bensolomon1
5K Followers 3K Following Lung cancer medical oncologist at Peter MacCallum Cancer Centre | Views are my own
pfoskett @pdf104
20 Followers 132 Following
Quibim @QuibimBiomarker
2K Followers 1K Following Transforming imaging data into actionable predictions
Giorgia Ferrari @GiorgiaFerrari2
6 Followers 47 Following Oncology resident at University of Turin @unito
Jen McKee @Triscuit2712
33 Followers 805 Following
Tetsuya Mitsudomi @t_mitsudomi
1K Followers 544 Following Professor, Thoracic Surgery, Kindai University, Osaka, Japan, Interested in Translational research of lung cancer. Play the cello a little bit.
Mouillot Pierre @MouillotPiR
0 Followers 37 Following
Michelle Rosario @MichelleRos90
4 Followers 44 Following Macmillan Lung Cancer Clinical Nurse Specialist @WestMidHospital @ChelwestFT @macmillancancer
furkan atasever @furkanatasever6
51 Followers 187 Following
🙏🏽💐🇮🇳D.. @DrGPMohanty
489 Followers 2K Following Son,Brother,Husband,Father,Radiation Oncologist with special interest in High Precision Radiotherapy.Practicing Stereotactic Radiotherapy since 10 years
Janclark @Janclarkgirls
119 Followers 158 Following Work in med tech Mother to four girls one whom was diagnosed w #ALKPositive #lungcancer at 20.@OncogeneCancer. #ResearchSavesLives
Αγγελική Σο.. @angelikisouri
10 Followers 50 Following Patient Advocate, #lungcancer, BoD @fairlifelcc, BoD @lungcancerEU, ex. partner and BoD J. Stavropoulos S.A.
xudong @xudong12345
36 Followers 517 Following
Shelly S @shellynshy
94 Followers 894 Following 62 year old gal. Dx with stage 4 nsclc 8 years ago totally out of the blue. Riding the #afatinib #EGFR train as long as I can. #NSCLC
. @hipilangstrumpf
572 Followers 2K Following https://t.co/73hEdqA4KZ Radiologist w/ BSc in Computer Eng. and Msc in Biomedical Eng. GSL 132, Boun, KULeuven, ETHZurich, CTF İng., CTF Radyoloji
Shane OBrien @shane75289
54 Followers 106 Following
Young Kwang Chae, MD,.. @youngkwangchae
283 Followers 130 Following Medical Oncologist, Translational Physician-Scientist, Co-Director of Developmental Therapeutics Lurie Cancer Center at Northwestern University
Shaun Hill @ShaunHill1970
7 Followers 70 Following Accountant. Stage 4 ALK+ lung cancer patient since January 2022. Occasionally dabbles with statistics.
bio86 @alisti878
34 Followers 157 Following PhD, Molecular Biologist, Dipartiment of Oncology, University of Turin
Sonya Bollino @SonyaBollino
4 Followers 127 Following
fabrizio @fabrizioUSA
109 Followers 548 Following
Pheel @Pheel267
252 Followers 975 Following Medico Chirurgo, MD, specializzando in Oncologia, Milano // MD, Oncology Resident (Milan), Lung Cancer as main topic
Dr Adil Daing Officia.. @dradiliqbaldain
607 Followers 4K Following Consultant Surgical Oncology And Robotic Surgery. Member American-ASCO,SSO And European ESMO Cancer Societies. Rt's Not Endorsements.
Evan @Evan734
72 Followers 2K Following
Wu Gong @Gong__Wu
4 Followers 56 Following
Christine Garcia, MD,.. @christinemphmd
2K Followers 4K Following Thoracic Oncologist & Non-malignant Hematologist @NYPHospital @WeillCornell | PD @WCMHemOncFellow | Spouse, Mom & Sheltie Owner | Tweets are mine.
Will Davis @William_davis28
68 Followers 321 Following PhD candidate in the Dunedin School of Medicine. Interested in tumour cell responses to drug treatment, drug tolerance, and lncRNAs. Lover of the outdoors.
Vicky @zhangku49152502
24 Followers 639 Following
Judy Ganeles @jfgane
42 Followers 727 Following
eric xu @ericxu_cn
67 Followers 151 Following
balaji jegannathan @oncobalaji
77 Followers 750 Following
G @gchebly
158 Followers 404 Following
おくきち @41fJN182JHf8WDk
457 Followers 441 Following S2,S5〜17最高ランク/最高🌎13位🇯🇵5位キラフレンド✨目指して頂ける方募集 交換は非対面、推しはゾロア☆レックウザ☆
Victoria Robinson @Victori77523622
25 Followers 128 Following
Young Lung Cancer Ini.. @YoungLungCancer
350 Followers 871 Following A division of a 501(c)(3) organization aimed at creating visibility, empowerment, and hope for young adults diagnosed with lung cancer before the age of 50.
S98121058林建佑 @s98121058
0 Followers 15 Following
Christin Kaiander @ChristinKaiand1
12 Followers 206 Following
Sina Mansoorian @aghadindin
10 Followers 130 Following
Tejas Patil @TejasPatilMD
569 Followers 208 Following Thoracic oncologist @CUCancerCenter, via @Penn & @KeckMedUSC | Interests in #biomarkers & #PrecisionOncology in #lungcancer | Piano and ski on the side.
Jen Lovick, PhD Journ.. @drjkyl
1K Followers 5K Following Executive Editor Gold #OpenAccess Journals @ Sage Publishing, Technology in Cancer Research & Treatment @TCRT_Cancer (IF 2.8) Comments/Opinions=mine #oncology
ZhuoLin Yang @ZhuolinY1821
0 Followers 1 Following
Sureeporn Teparaksa @PloyjarasSeang
40 Followers 56 Following
YS@thoracic surgery @112ys
309 Followers 330 Following 学生時代は横浜で塾講をやっていた数学好きの呼吸器外科専門医です。今のマイブームは機械学習です。手術ができるデータサイエンティストを目指してます。
Amalya Sargsyan @amalsargsyan
1K Followers 1K Following Medical Oncologist 🩺 | Yeolyan Oncology and Hematology Center🚀 🇦🇲l Research Fellow at Immune Oncology Research Institute 🧪| MSc in Precision Medicine 🇨🇾
Stephen V Liu, MD @StephenVLiu
24K Followers 3K Following Director of Thoracic Oncology & Developmental Therapeutics @Georgetown @LombardiCancer; Host @IASLC Podcast; Chair #DCLung24 #TexasLung24 #HereWeGo
Vivek Subbiah, MD @VivekSubbiah
34K Followers 2K Following Chief, Early-Phase Drug Development|@SarahCannonDocs #Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.
Jarushka Naidoo @DrJNaidoo
9K Followers 936 Following Professor of Medical Oncology @CancerCentreIre | Thoracic Oncologist | Immunotherapy & Immune toxicity | Adjunct faculty Johns Hopkins University
ESMO - Eur. Oncology @myESMO
75K Followers 874 Following The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology community’s work.
d.planchard @dplanchard
6K Followers 208 Following Thoracic Oncologist - Prof at University Paris Saclay - Head of Thoracic Group and CICT, Medical Oncology Dpt- Gustave Roussy - Villejuif - France 🇫🇷
IASLC @IASLC
19K Followers 2K Following The International Association for the Study of Lung Cancer is the only global organization dedicated solely to the study of lung cancer. #LCSM
Balazs Halmos @DrSteveMartin
8K Followers 3K Following Thoracic/precision oncology 🇭🇺🇺🇸 Country music singer- The White Lungs
Sanjay Popat @DrSanjayPopat
7K Followers 591 Following Thoracic Oncologist @royalmarsdenNHS, Professor @ICR_London; Chair @BTOGorg; views are my own.
Narjust Florez, MD, F.. @NarjustFlorezMD
23K Followers 2K Following Assc. Director CCEP & Thoracic Oncologist @DanaFarberNews & @Harvardmed| Lung Ca in Women | Editor @Jamaonc | Co-founder @LatinasInMed | @Florez_Lab | Free
Drew Moghanaki 🐕 @DrewMoghanaki
11K Followers 1K Following MD, MPH - Lung Cancer Specialist and Professor, David Geffen School of Medicine at UCLA | Co-Director, Lung Precision Oncology Program, VA Greater Los Angeles
Andres F. Cardona @AndresFCardonaZ
8K Followers 4K Following Pursue knowledge, mentor students, collaborate globally, and push boundaries. Everything else is just noise in the academic concert.
Jordi Remon @JordiRemon
3K Followers 97 Following Medical Oncologist - Thoracic tumors. Personalized treatment approches @EORTC
Alfredo Addeo MD @Alfdoc2
2K Followers 121 Following Medical Oncologist, department of oncology at the University hospital of Geneva (HUG). All opinions expressed here are my own
Lecia Sequist, MD, MP.. @LeciaSequist
10K Followers 2K Following Program Director, Cancer Early Detection & Diagnostics @MGHCancerCenter #Equity @mgh_fhs #NoOneDeservesLungCancer #ScreeningSavesLives @IASLC She/her
Ivy Elkins @ivybelkins
6K Followers 4K Following Co-Founder, @EGFRResisters LC Patient Group; writer for https://t.co/W6HLnN0ibZ; lc advocate/survivor; dx stage IV 2013, @Princeton & @Wharton alum.
Christine Lovly, MD, .. @christine_lovly
7K Followers 938 Following Thoracic Oncologist & Physician Scientist @VUMC. Member @AACR Board of Directors. Dog lover. Believer that kindness counts. Views = my own. #LCSM @Oncoalert
Annals of Oncology @Annals_Oncology
47K Followers 520 Following Medical oncology journal with a specific interest on targeted agents, immune therapies, personalised medicine, molecular pathology, bioinformatics, and more.
Patrick Forde @FordePatrick
5K Followers 2K Following Lung cancer & Mesothelioma @HopkinsThoracic @HopkinsKimmel Immunotherapy believer. 🇮🇪 🇺🇸
Julien Mazieres @JulienMazieres
4K Followers 158 Following MD, PhD, Prof of Respiratory Medicine, Thoracic Oncology Specialist @CHUdeToulouse, @IUCToncopole. Researcher, INSERM @crctoncopole #LCSM 🏃♂️ 🚴 🏉
Dr. Estela Rodriguez @Latinamd
6K Followers 3K Following Associate Director Community Outreach- DEI- 🫁Thoracic Oncology, University of Miami @SylvesterCancer , 🇵🇷Boricua, Co-founder @KidsHelpingKidsSucceed
John Haanen @HaanenJohn
815 Followers 139 Following Medical oncologist. @myESMO, @esmo_iotech, @NKI_nl, @oncoUNILCHUV
AACR @AACR
112K Followers 2K Following The mission of the American Association for Cancer Research is to prevent and cure cancer through research, education, communication, and collaboration.
Clinical Lung Cancer @ClinicalLung
985 Followers 246 Following Peer-reviewed journal covering clinical and translational research of lung and other thoracic cancers published by Elsevier. EIC: Antoinette Wozniak MD
cadranel jacques @CadranelJ
2K Followers 66 Following Chest Department, Thoracic Oncology Center/Rare Pulmonary Diseases - Hôpital Tenon APHP-Sorbonne Université. "Patients first and foremost". Tweets are my own.
Roy Herbst @DrRoyHerbstYale
6K Followers 445 Following
Misako Nagasaka @MNagasaka
794 Followers 308 Following Thoracic Oncologist at University of California Irvine
Raffaele Califano @caliraf
948 Followers 455 Following Thoracic Oncologist @TheChristieNHS, Honorary Professor @UoM_DCS . Member @myesmo Educational Publication WG. Views are my own No DMs or medical advice given.
Michael Duruisseaux @MDuruisseaux
689 Followers 92 Following Thoracic Oncologist/Early Phase @CHUdeLyon Deputy Director @CHUdeLyon Cancer Institute Board Member @IFCTlung President 🇨🇵 Cooperative Oncology Group Network
Zosia Piotrowska @ZPiotrowskaMD
2K Followers 387 Following Thoracic oncologist and lung cancer researcher, @mghcancenter. Mom, wife, daughter. All views are my own.
Joshua Bauml, MD @Jbauml
6K Followers 1K Following R&D at J&J Innovative Medicine. Medical oncologist. Views mine. Tweets are not medical advice. (He/him/his)
ALK Positive @ALKPositiveinc
2K Followers 909 Following We are a patient-driven organization, dedicated to improving the life expectancy & quality of life for ALK-positive cancer patients worldwide. #StrongerTogether
UKALK+ @UKALK1
1K Followers 645 Following ALK+ lung cancer patient support & advocacy charity #ifyouhavelungsyoucangetlungcancer
Exon 20 Group, a mult.. @Exon20Group
2K Followers 4K Following Global org: patients/carers, HCPs, pharma, labs, scientists, working to cure #NSCLC #HER2 & #EGFR #Exon20 insertions (in 25 cancers +) [email protected]
Garth Nicholas @Garth_Nicholas1
3K Followers 356 Following A Canadian oncologist. No pharma conflicts.
EGFR Positive UK @EgfrUk
970 Followers 435 Following The only UK charity for EGFR+ lung cancer advocacy, empowerment & support 💜 Our community offers hope & learning for those living with EGFR+. Get involved ⤵
Isabel Preeshagul @ipreeshagul
2K Followers 820 Following Thoracic Medical Oncologist at Memorial Sloan Kettering Cancer Center
Corey Langer @CoreyLangerMD
1K Followers 297 Following Full time thoracic medical oncologist, husband, father and grandfather. Part time poet.
Benjamin Levy @benlevylungdoc
3K Followers 568 Following Clinical Director - Johns Hopkins Sidney Kimmel Cancer Center @ Sibley Memorial Hospital - Washington, D.C.
Daniel Tan @danieltanmd
911 Followers 413 Following
Henning Willers, MD @HenningWillers
5K Followers 822 Following Director #RadBio & Thoracic #RadOnc @MGHCancerCenter | 📞 617-726-5184 | @IJROBP #RadBio Editor | @OncoAlert | #HeforShe #NoManels #DEI | Views=Private | He/Him
Nirmal Raut @oncologician
6K Followers 6K Following Masters of molecular oncology (CNIO ) Medical Oncologist by profession (Lung is close to my heart), researcher by passion, precision oncology,liquid biopsy.
Anna Nowak @perth_meso_dr
3K Followers 864 Following University of Western Australia Deputy Vice Chancellor (Research). Researcher. Medical oncologist in #Mesothelioma, no longer practicing. Tweets my own.
Tony Mok @TonyMok9
5K Followers 71 Following A lung cancer researcher seeking truth. A doctor seeking hope. A writer seeking inspiration. A food lover seeking food.
Joshua Sabari, MD @JSabari
2K Followers 864 Following Thoracic medical oncologist, Perlmutter Cancer Center NYU Langone Health. Tweets are my own and not medical advice
Marc Ladanyi @MLadanyi
3K Followers 206 Following Molecular pathologist & cancer scientist: focus on clinical cancer genomics, targeted therapies, sarcomas, lung ca, mesothelioma, & vinyl LPs @MSKCancerCenter
Lizza Hendriks @HendriksLizza
879 Followers 136 Following Pulmonologist - thoracic oncology, esp brain metastases @MaastrichtUMC @GROW_UM- member @DeJongeAkademie - @myESMO #LungCancer faculty - @EORTC - Views my own
Nicolas Girard @nicogirardcurie
2K Followers 33 Following Lung cancer and rare thoracic tumors specialist.
ASCO @ASCO
147K Followers 2K Following Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.
Lung Cancer Pall @lungcancerpall
253 Followers 246 Following
Charles Swanton @CharlesSwanton
15K Followers 819 Following Francis Crick Institute and UCL Hospitals @CR_UK Cancer Evolution and Genome Instability Lung Oncologist Air Pollution and Drug Resistance Fair Weather 🚴
KRASKickers @KRASKickers
3K Followers 5K Following #KRAS 🎯cancer Knowledge + Research + Advocacy = Survivorship #Patient #Empowerment group Healthcare gap is #KRAShole
Dr. Linda Coate @lindacoate
2K Followers 3K Following Medical oncologist, researcher, patient advocate @HSELive. Ass Prof Medicine @UL_GEMS. #lcsm #bcsm Personal views not employers
RETpositive @RETpositive
1K Followers 700 Following Research, news and advocacy for caregivers and patients impacted by RET-driven cancers. Research is hope!🧬🔬
Fred R. Hirsch @fred_hirsch
3K Followers 61 Following I am Executive Director at the Center for Thoracic Oncology at Mount Sinai Hospital , NYC and Professor of Medicine at Icahn Medical School at Mount Sinai, NY
IFCT lung @IFCTlung
2K Followers 137 Following IFCT is a French cooperative thoracic intergroup sponsoring clinical research to improve survival and quality of life of patients with lung cancer.
Ticiana Batista (Leal.. @LealTiciana
2K Followers 559 Following Medical Thoracic Oncology, Clinical trials, lung cancer
Geoff Oxnard MD @geoff_oxnard
4K Followers 132 Following Drug & diagnostic developer | Thoracic oncology, Boston Medical Center | Husband, father of 4, splitter of wood | Opinions my own
Dr. Amy C. Moore @acmoorephd
4K Followers 4K Following Scientist and advocate. VP, Global Engagement and Research Partnerships @LUNGevity. Team #CANCAN @cancergrand. Views = mine.
Mark Awad @DrMarkAwad
2K Followers 472 Following Director of Clinical Research, Associate Professor, Thoracic Oncology @DanaFarber | Lung Cancer Immunotherapy Research | Tweets my own
Melissa L. Johnson @MLJohnsonMD2
3K Followers 631 Following Medical oncologist whose focus is drug development for lung cancer patients being treated in the community.
leorahornmd @HornLeora
1K Followers 201 Following
A/Prof Tom John @TommyJohn00
4K Followers 3K Following Medical Oncologist, Translational Researcher, Peter Mac. Tweets are my own opinions. Musician (@mayhemtomi) https://t.co/f3ccD2MSX3
Gʀᴇɢᴏʀʏ Rɪ�.. @RielyMD
4K Followers 1K Following Medical Oncologist in NYC. Clinical focus on lung cancer and thymic malignancies. COI: https://t.co/2CQnmp3kC7
Suresh S. Ramalingam,.. @RamalingamMD
5K Followers 977 Following Executive Director @WinshipAtEmory | Professor @EmoryUniversity |Associate VP for Cancer, Woodruff Health Sciences Center I Opinions are my own.
Establishing reliable comparative outcome measures in #lungcancer 🫁 is ever more important w/ screening criteria expansion + growth of #valuebasedpayment In our study 📈: hospital-level peri-op mortality was associated with future 5-year survival. sciencedirect.com/science/articl…
Some guidance on the management of adverse events with sotorasib in #KRAS G12C NSCLC @LungCaJournal. Most common grade 2+ adverse events were diarrhea and hepatotoxicity, esp if given after immunotherapy. Close monitoring & dose modification important. lungcancerjournal.info/article/S0169-…
Clinical significance of inter-assay discrepancy in PD-L1 evaluation The effect of the discrepancy between 22C3 and SP142 tests on response rates: TPS>50% (22C3) ORR (pembro) SP142-➡️18% SP142+➡️83% The cause of this discrepancy could be attributed to differences in CD274…
An audit of the biomarkers ATLAS project (biomarkersatlas.com) is available @LungCaJournal. A knowledge-based database integrating clinical and molecular records from 80 referral Italian institutions led by Dr. @UmbertoMalapel1. lungcancerjournal.info/article/S0169-…
📌 The latest ESMO Guidelines webinar on non-oncogene-addicted metastatic #NSCLC is now available on-demand. Access the resources with your free ESMO account and learn how these recommendations can assist you in your daily practice. 🔗 ow.ly/Bo5Y50R4SY4
@StephenVLiu @LungCaJournal Been doing one down here! 😃 trog.com.au/trials/trog-17… @TOGAANZ @TROGfightcancer
Pragmatic guide for management of lorlatinib adverse events now @LungCaJournal. Lorlatinib approved for #ALK NSCLC and very potent with high CNS efficacy but important to anticipate and mitigate toxicity including lipids and neurocognitive effects. lungcancerjournal.info/article/S0169-…
A fine review of the data and usefulness of MRD in clinical practice for both doctors and patients by @JordiRemon @GustaveRoussy ! Predictive vs. prognostic? More work to do... #ELCC24 @myESMO @IASLC
Ready for the 2nd day at #ELCC24 after a great 1st day that can be summarized with this @myESMO daily news article: "How ‘precise’ has lung cancer treatment become?" #ESMOAmbassadors dailyreporter.esmo.org/european-lung-…
See this month’s highlights from the @myESMO portfolio. Featured content from @Annals_Oncology, @ESMO_Open, @esmo_iotech, @TheBreastOnline, @LungCaJournal, Cancer Treatment Reviews and Clinical Lymphoma Myeloma and Leukemia spkl.io/60194QHC9
@Annals_Oncology @ESMO_Open @esmo_iotech @TheBreastOnline @LungCaJournal Cancer Treatment Reviews and Clinical Lymphoma Myeloma and Leukemia
Here is a collection of papers recently published in ESMO’s premier journals carefully selected to reflect the themes of the meeting. ➡️ spkl.io/60164x4Gy
ESMO Targeted Anticancer Therapies Congress 2024 offers participants a glimpse into the future of anticancer therapies, focusing on promising new targets and agents with a particular emphasis on early drug development.
Outcomes with chemo-immunotherapy by #KRAS, STK11, and KEAP1 across PDL1 strata @LungCaJournal. KRAS mt enriched in PDL1 high but KRAS with co-mutations in STK11 and KEAP1 enriched in PDL1 negative. Poor OS in KRAS mt with PDL1 0% driven by STK11/KEAP1. lungcancerjournal.info/article/S0169-…
Overview of management of NUT carcinoma in Germany @LungCaJournal. Most had BRD4-NUTM1 fusion, most common initial therapy is surgery, ifosfamide-based regimens associated with better PFS. Initial misdiagnosis an issue in 31 % of the cases. lungcancerjournal.info/article/S0169-…
Last month @LungCaJournal: study of higher risk of hospitalization for Black patients, co-authored by research assistant professor Chih-Yuan Hsu w/colleagues @VUMCHemOnc @hopkinskimmel @TischCancer & more #TERAVOLT #HealthEquity sciencedirect.com/science/articl… #COVID19 #cancer
We’re delighted to welcome @tompowles1 as the new Editor-in-Chief of @Annals_Oncology. Tom outlines his focus for the future in “Passing the baton and raising the bar” spkl.io/60134QUiX @myESMO
Results from phase III CANOPY-2 trial @LungCaJournal exploring canakinumab (IL-1 beta inhibitor) in NSCLC. Randomized 237 pts with prior chemo and IO to canakinumab + docetaxel vs placebo + docetaxel. No impact on OS (10.5m vs 11.3m, HR 1.06). lungcancerjournal.info/article/S0169-…
In @LungCaJournal #CANOPY-2 shows: ➡️Canakinumab + Docetaxel = Docetaxel, no improvement in PFS/OS with combination IMO: Even in this study, we continue to see the prognostic role of ctDNA + vs - 👇@LungCancerRx bit.ly/47KMMgE @OncoAlert
Our real-world report on afatinib in pts with #NRG1 fusion positive NSCLC now @LungCaJournal. RR with afatinib 38% (RR 44% as first-line) with mPFS 5.5m. Reminder that NRG1 fusions are challenging to find due to rarity and size of gene (RNA-seq is best). lungcancerjournal.info/article/S0169-…
Trends for United States
You might like
